BBH Holdings Information

BBH is an equity ETF with a total of 25 individual holdings. The top holdings are Amgen stock at 14.19%, Gilead Sciences at 13.48%, Vertex Pharmaceuticals at 7.92%, Regeneron Pharmaceuticals at 6.08%, and argenx SE at 6.05%.

Total Holdings

Top 10 Percentage

69.05%

Asset Class

Equity

ETF Category

Health

Assets

365.74M

PE Ratio

21.05

Breakdown by Sector

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	14.19%	151,337
2	GILD	Gilead Sciences, Inc.	13.48%	384,392
3	VRTX	Vertex Pharmaceuticals Incorporated	7.92%	66,073
4	REGN	Regeneron Pharmaceuticals, Inc.	6.08%	35,604
5	ARGX	argenx SE	6.05%	26,460
6	IQV	IQVIA Holdings Inc.	4.68%	92,283
7	RVMD	Revolution Medicines, Inc.	4.55%	107,767
8	NTRA	Natera, Inc.	4.39%	72,850
9	BIIB	Biogen Inc.	3.96%	74,341
10	ALNY	Alnylam Pharmaceuticals, Inc.	3.74%	45,446
11	UTHR	United Therapeutics Corporation	3.49%	23,507
12	ILMN	Illumina, Inc.	3.38%	74,035
13	MRNA	Moderna, Inc.	3.13%	223,594
14	ONC	BeOne Medicines AG	3.04%	40,029
15	INSM	Insmed Incorporated	2.93%	102,766
16	NBIX	Neurocrine Biosciences, Inc.	2.44%	53,830
17	INCY	Incyte Corporation	2.40%	87,469
18	BNTX	BioNTech SE	2.16%	88,761
19	ICLR	ICON Public Limited Company	1.75%	42,093
20	BMRN	BioMarin Pharmaceutical Inc.	1.38%	90,259
21	CRL	Charles River Laboratories International, Inc.	1.37%	27,137
22	TECH	Bio-Techne Corporation	1.36%	94,403
23	QGEN	Qiagen N.V.	1.07%	104,756
24	TEM	Tempus AI, Inc.	1.06%	75,062
25	n/a	Us Dollar	-0.01%	45,843

As of Jun 5, 2026